{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of 3-D Fracture-Site Motion in Supracondylar Femoral Fractures"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was performed using a computer-generated sequence"
      },
      "Participants": {
        "score": 2,
        "evidence": "Sixty-six patients with supracondylar femoral fractures (OTA/AO classification of 33A or 33C) were included. Participants were eligible if they had a supracondylar femoral fracture and were treated with locking-plate fixation."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Construct-specific finite element (FE) modeling simulated 3-D fracture-site motion."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the effect of three-dimensional (3-D) fracture-site motion on callus formation in supracondylar femoral fractures treated with locking-plate fixation."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was callus formation, assessed radiographically at six, twelve, and twenty-four weeks postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group allocation."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Sixty-six participants were randomised, with 33 in each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Longitudinal motion promoted callus formation at twelve and twenty-four weeks (p = 0.017 for both), while shear inhibited callus formation (p = 0.017 and p = 0.022, respectively)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}